Showing results (441-450 of 513) with videos related to
Sort By:
Pageof 52
JTO Clinical and Research Reports|July 22, 2024
Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 TrialBenjamin J Solomon, Ibiayi Dagogo-Jack, Se-Hoon Lee, et al.BMC Cancer|May 9, 2024
Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09Sun Young Kim, Jee Hyun Kim, Tae-Yong Kim, et al.Journal of Neuro-Oncology|September 23, 2011
Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatmentHee-Jun Kim, Seock-Ah Im, Bhumsuk Keam, et al.Journal for Immunotherapy of Cancer|October 20, 2020
Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purityTae Hee Hong, Hongui Cha, Joon Ho Shim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion CohortLaura Q M Chow, Robert Haddad, Shilpa Gupta, et al.Journal for Immunotherapy of Cancer|October 31, 2025
Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitorYeong Hak Bang, Geun-Ho Park, Jin Woo Oh, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 19, 2025
Perioperative Pembrolizumab for Locally Advanced Thymic Epithelial Tumors: A Single-Arm, Phase 2 TrialYeong Hak Bang, Jae Myoung Noh, Boram Lee, et al.Experimental & Molecular Medicine|November 1, 2023
Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detectionSu Yeon Kim, Seongmun Jeong, Wookjae Lee, et al.Cancer|May 29, 2023
A phase 2 multicenter study of docetaxel-PM and trastuzumab-pkrb combination therapy in recurrent or metastatic salivary gland carcinomasJiyun Lee, Sehhoon Park, Hyun Ae Jung, et al.JAMA Surgery|February 18, 2026
Preoperative Circulating Tumor DNA Detection and Risk Stratification in Esophageal Squamous Cell CarcinomaTae Hee Hong, Jun-Gi Jeong, Seong Yong Park, et al.Pageof 52